skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of Small Molecules that Inhibit the Disordered Protein, p27Kip1

Journal Article · · Scientific Reports
DOI:https://doi.org/10.1038/srep15686· OSTI ID:1261472
 [1];  [2];  [3];  [4];  [2];  [3];  [5];  [6]
  1. Dept. of Structural Biology, Memphis, TN (United States); Dept. of Development Neurobiology, Memphis, TN (United States)
  2. Dept. of Structural Biology, Memphis, TN (United States)
  3. St. Jude Children's Research Hospital, Memphis, TN (United States)
  4. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
  5. Dept. of Development Neurobiology, Memphis, TN (United States)
  6. Dept. of Structural Biology, Memphis, TN (United States); Univ. of Tennessee Health Science Center, Memphis, TN (United States)

In disordered proteins we see that they are highly prevalent in biological systems. They control myriad signaling and regulatory processes, and their levels and/or cellular localization are often altered in human disease. In contrast to folded proteins, disordered proteins, due to conformational heterogeneity and dynamics, are not considered viable drug targets. We challenged this paradigm by identifying through NMR-based screening small molecules that bound specifically, albeit weakly, to the disordered cell cycle regulator, p27Kip1 (p27). Moreover, two groups of molecules bound to sites created by transient clusters of aromatic residues within p27. Conserved chemical features within these two groups of small molecules exhibited complementarity to their binding sites within p27, establishing structure-activity relationships for small molecule: disordered protein interactions. Finally, one compound counteracted the Cdk2/cyclin A inhibitory function of p27 in vitro, providing proof-of- principle that small molecules can inhibit the function of a disordered protein (p27) through sequestration in a conformation incapable of folding and binding to a natural regulatory target (Cdk2/cyclin A).

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH); US Department of the Navy, Office of Naval Research (ONR)
Grant/Contract Number:
AC05-00OR22725; R01CA082491; N000140911014; F32GM113290
OSTI ID:
1261472
Journal Information:
Scientific Reports, Vol. 5, Issue 5; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 59 works
Citation information provided by
Web of Science

References (56)

Disorder, Promiscuity, and Toxic Partnerships journal July 2009
Scaffold composition and biological relevance of screening libraries journal August 2007
Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease journal February 2014
Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. journal October 1996
CDK inhibitors: positive and negative regulators of G1-phase progression journal June 1999
Discovering High-Affinity Ligands for Proteins: SAR by NMR journal November 1996
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor journal May 2014
Role of Intrinsic Flexibility in Signal Transduction Mediated by the Cell Cycle Regulator, p27Kip1 journal February 2008
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald journal August 2013
NMR methods in fragment screening: theory and a comparison with other biophysical techniques journal November 2009
Classification of Intrinsically Disordered Regions and Proteins journal December 2013
Comment on “Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc” journal September 2016
Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A journal September 1998
Low molecular weight inhibitors of Myc–Max interaction and function journal September 2003
A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma journal July 2009
p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding journal March 2004
Ligand Clouds around Protein Clouds: A Scenario of Ligand Binding with Intrinsically Disordered Proteins journal October 2013
Regulated unfolding of proteins in signaling journal February 2013
Computational Identification of Slow Conformational Fluctuations in Proteins journal December 2009
A decade of fragment-based drug design: strategic advances and lessons learned journal February 2007
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy journal June 1999
Prediction of ‘drug-likeness’ journal March 2002
Probing the Role of Nascent Helicity in p27 Function as a Cell Cycle Regulator journal October 2012
Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability journal January 2012
A ‘Rule of Three’ for fragment-based lead discovery? journal October 2003
Tight Regulation of Unstructured Proteins: From Transcript Synthesis to Protein Degradation journal November 2008
Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins journal November 2008
Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry journal July 2005
Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules journal November 2008
Auditory Hair Cell-Specific Deletion of p27Kip1 in Postnatal Mice Promotes Cell-Autonomous Generation of New Hair Cells and Normal Hearing journal November 2014
Mammalian cochlear supporting cells can divide and trans-differentiate into hair cells journal June 2006
Molecular Field Extrema as Descriptors of Biological Activity:  Definition and Validation journal March 2006
NMRPipe: A multidimensional spectral processing system based on UNIX pipes journal November 1995
Experiences in fragment-based drug discovery journal May 2012
High-Throughput Screening Reveals Alsterpaullone, 2-Cyanoethyl as a Potent p27Kip1 Transcriptional Inhibitor journal March 2014
Cdk-Inhibitory Activity and Stability of p27Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases journal January 2007
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells journal May 1996
The Role of the LH Subdomain in the Function of the Cip/Kip Cyclin-Dependent Kinase Regulators journal May 2011
Disordered p27Kip1 Exhibits Intrinsic Structure Resembling the Cdk2/Cyclin A-bound Conformation journal November 2005
Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy journal December 2014
PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization journal September 2002
Strategic Pooling of Compounds for High-Throughput Screening journal July 1999
Intrinsic Protein Disorder and Interaction Promiscuity Are Widely Associated with Dosage Sensitivity journal July 2009
Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc journal June 2009
CP-HISQC: a better version of HSQC experiment for intrinsically disordered proteins under physiological conditions journal February 2014
Reactive compounds and in vitro false positives in HTS journal September 1997
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets journal January 2013
Thermodynamic characterization of interactions between p27Kip1 and activated and non-activated Cdk2: Intrinsically unstructured proteins as thermodynamic tethers journal February 2006
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex journal July 1996
Fragment-Based Approaches in Drug Discovery and Chemical Biology journal June 2012
Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing journal March 2015
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer journal September 2002
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest journal September 2002
Heteronuclear NMR Spectroscopy for Lysine NH 3 Groups in Proteins:  Unique Effect of Water Exchange on 15 N Transverse Relaxation journal March 2007
Disordered Binding of Small Molecules to Aβ(12–28) journal October 2011
p27Kip1 links cell proliferation to morphogenesis in the developing organ of Corti journal April 1999

Cited By (8)

Dynamic anticipation by Cdk2/Cyclin A-bound p27 mediates signal integration in cell cycle regulation journal April 2019
Methods of probing the interactions between small molecules and disordered proteins journal June 2017
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss journal March 2018
The lineage-specific, intrinsically disordered N-terminal extension of monothiol glutaredoxin 1 from trypanosomes contains a regulatory region journal September 2018
Targeting the molecular chaperone SlyD to inhibit bacterial growth with a small molecule journal February 2017
Targeting intrinsically disordered proteins involved in cancer journal October 2019
Identification of a Drug Targeting an Intrinsically Disordered Protein Involved in Pancreatic Adenocarcinoma journal January 2017
Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target journal June 2018

Similar Records

Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase
Journal Article · Mon Jul 19 00:00:00 EDT 2010 · Mol. Cell · OSTI ID:1261472

CDK inhibitors, p21{sup Cip1} and p27{sup Kip1}, participate in cell cycle exit of mammalian cardiomyocytes
Journal Article · Fri Jan 17 00:00:00 EST 2014 · Biochemical and Biophysical Research Communications · OSTI ID:1261472

p27{sup Kip1} inhibits tissue factor expression
Journal Article · Fri Oct 04 00:00:00 EDT 2013 · Biochemical and Biophysical Research Communications · OSTI ID:1261472

Related Subjects